You are on Trendlyne United States. Click here to go to India website or make United States as your default
person reading

About Milestone Pharmaceuticals Inc - Company Information, Overview, History and Profile

What does Milestone Pharmaceuticals Inc do?

Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).

Milestone Pharmaceuticals Inc Management structure

All Gross Remunerations are in USD
Mr. Joseph G. Oliveto
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year
Mr. Amit Hasija
Chief Financial Officer, Principal Accounting Officer and Executive Vice President, Corporate Development
-
2024
Gross Remuneration
Year

Milestone Pharmaceuticals Inc Board of directors

All Gross Remunerations are in USD
Mr. Andrew Saik
Independent Director
-
2024
Gross Remuneration
Year
Ms. Debra K. Liebert
Independent Director
-
2024
Gross Remuneration
Year
Dr. Richard C. Pasternak, M.D.
Independent Director
-
2024
Gross Remuneration
Year
Mr. Stuart M. Duty
Independent Director
-
2024
Gross Remuneration
Year
Mr. Joseph C. Papa
Director
-
2024
Gross Remuneration
Year
Mr. Joseph G. Oliveto
Director, President and Chief Executive Officer
-
2024
Gross Remuneration
Year